You just read:

Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease

News provided by

Jazz Pharmaceuticals plc , Gentium S.p.A.

31 Mar, 2014, 13:00 BST